Regentatlantic Capital LLC Pfizer Inc Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 440,788 shares of PFE stock, worth $12.8 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

440,788

Previous 450,439 2.14%

Holding current value

$12.8 Million

Previous $23.6 Million 18.33%

% of portfolio

0.58%

Previous 0.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $422,327 - $515,556	-9,651 Reduced 2.14%	440,788 $19.3 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $168,996 - $200,377	3,632 Added 0.81%	450,439 $23.6 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $275,964 - $341,954	-6,032 Reduced 1.33%	446,807 $23.1 Million
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $404,481 - $599,576	-9,789 Reduced 2.12%	452,839 $26.7 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $221,370 - $284,368	5,640 Added 1.23%	462,628 $19.9 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $116,563 - $132,047	-3,246 Reduced 0.71%	456,988 $17.9 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $388,550 - $438,207	-11,602 Reduced 2.46%	460,234 $16.7 Million
Q4 2020 Feb 04, 2021	SELL	$33.47 - $42.56 $102,317 - $130,105	-3,057 Reduced 0.64%	471,836 $17.4 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $505,936 - $593,578	15,935 Added 3.47%	474,893 $17.4 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $225,448 - $273,501	7,485 Added 1.66%	458,958 $15 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $635,664 - $908,226	-23,517 Reduced 4.95%	451,473 $14.7 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $173,817 - $197,260	-5,280 Reduced 1.1%	474,990 $18.6 Million
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $402,973 - $522,538	-12,403 Reduced 2.52%	480,270 $17.3 Million
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $371,722 - $417,359	-10,052 Reduced 2.0%	492,673 $21.3 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $22,237 - $24,431	-593 Reduced 0.12%	502,725 $21.4 Million
Q4 2018 Jan 30, 2019	BUY	$38.47 - $43.86 $1.71 Million - $1.95 Million	44,571 Added 9.72%	503,318 $22 Million
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $415,087 - $503,476	12,042 Added 2.7%	458,747 $20.2 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $614,153 - $654,749	18,622 Added 4.35%	446,705 $16.2 Million
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $436,815 - $506,766	13,689 Added 3.3%	428,083 $15.2 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $155,523 - $165,016	-4,676 Reduced 1.12%	414,394 $15 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $13 Million - $14.3 Million	419,070	419,070 $15 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Pfizer Inc Transaction History